STERIS plc acquires Surgical instrumentation assets of Becton, Dickinson and Company (V. Mueller, Snowden-Pencer, Genesis)

STERIS plc acquired Surgical instrumentation assets of Becton, Dickinson and Company (V. Mueller, Snowden-Pencer, Genesis) for $539.8 million (announced at $540 million); anticipated goodwill tax benefit with a present value of about $60 million, a transaction completed in August 2023, structured as all cash (funded with existing credit-facility borrowings). The deal was a Asset purchase (accounted for as a business combination under ASC 805).

Surgical instrumentation assets of Becton, Dickinson and Company (V. Mueller, Snowden-Pencer, Genesis) operates in Healthcare, is based in United States (carve-out from Becton, Dickinson and Company), had revenue of about approximately $170 million for BD's fiscal year ended September 30, 2023, with adjusted EBIT of about $45 million. STERIS bought the surgical-instrumentation, laparoscopic-instrumentation and sterilization-container assets of Becton, Dickinson and Company (NYSE: BDX), including the well-known V. Mueller, Snowden-Pencer and Genesis brands. The primarily-consumables product lines generated roughly $170 million of revenue in BD's fiscal year ended September 30, 2023, with adjusted EBIT of about $45 million. The assets were folded into STERIS's Healthcare segment.

Management said the added brands strengthen, complement and expand STERIS's Healthcare product offerings, with a focus on the operating room and sterile processing department that fits its core Healthcare customers.

Established, largely-consumable surgical-instrument brands with strong operating-room and sterile-processing positions adjacent to STERIS's existing franchise. present value of approximately $60 million in tax-deductible goodwill benefit; expands Healthcare consumables scale Integrated into the Healthcare segment

Advisory firms were not disclosed for this transaction.